Cargando…
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
SIMPLE SUMMARY: Cancer is a complex disease associated with deregulation of numerous genes. In addition, redundant cellular pathways limit efficiency of monotarget drugs in cancer therapy. MicroRNAs are a class of gene expression regulators, which often function by targeting multiple genes. This fea...
Autores principales: | Reda El Sayed, Soha, Cristante, Justine, Guyon, Laurent, Denis, Josiane, Chabre, Olivier, Cherradi, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198729/ https://www.ncbi.nlm.nih.gov/pubmed/34072348 http://dx.doi.org/10.3390/cancers13112680 |
Ejemplares similares
-
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
por: Oreglia, Maurine, et al.
Publicado: (2020) -
miRViz: a novel webserver application to visualize and interpret microRNA datasets
por: Giroux, Pierre, et al.
Publicado: (2020) -
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges
por: Cherradi, Nadia
Publicado: (2016) -
Rise and fall of thyroid radiologic density during the time course of amiodarone-induced thyrotoxicosis
por: Felix, Laure, et al.
Publicado: (2021) -
MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)